Home/Highlight Therapeutics/Marisol Quintero
MQ

Marisol Quintero

Chief Executive Officer

Highlight Therapeutics

Therapeutic Areas

Highlight Therapeutics Pipeline

DrugIndicationPhase
BO-112Basal Cell Carcinoma (BCC)Phase 2b
BO-212Not DisclosedResearch